BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 30265321)

  • 1. Chronic Hepatitis B Increases Liver-Related Mortality of Patients With Acute Hepatitis E: A Territorywide Cohort Study From 2000 to 2016.
    Lai JC; Wong GL; Yip TC; Tse YK; Lam KL; Lui GC; Chan HL; Wong VW
    Clin Infect Dis; 2018 Sep; 67(8):1278-1284. PubMed ID: 30265321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features of acute hepatitis E super-infections on chronic hepatitis B.
    Chen C; Zhang SY; Zhang DD; Li XY; Zhang YL; Li WX; Yan JJ; Wang M; Xun JN; Lu C; Ling Y; Huang YX; Chen L
    World J Gastroenterol; 2016 Dec; 22(47):10388-10397. PubMed ID: 28058019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients with liver cirrhosis.
    Wong GL; Chan HL; Mak CW; Lee SK; Ip ZM; Lam AT; Iu HW; Leung JM; Lai JW; Lo AO; Chan HY; Wong VW
    Hepatology; 2013 Nov; 58(5):1537-47. PubMed ID: 23389810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tenofovir disoproxil fumarate reduces hepatocellular carcinoma, decompensation and death in chronic hepatitis B patients with cirrhosis.
    Liu K; Choi J; Le A; Yip TC; Wong VW; Chan SL; Chan HL; Nguyen MH; Lim YS; Wong GL
    Aliment Pharmacol Ther; 2019 Nov; 50(9):1037-1048. PubMed ID: 31524304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of acute hepatitis E infection outcome in patients with and without chronic hepatitis B infection: a 10 year retrospective study in three regional hospitals in Hong Kong.
    Chow CW; Tsang SW; Tsang OT; Leung VK; Fung KS; Luk WK; Chau TN
    J Clin Virol; 2014 May; 60(1):4-10. PubMed ID: 24646686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of mortality in patients under treatment for chronic hepatitis B in Ethiopia: a prospective cohort study.
    Desalegn H; Aberra H; Berhe N; Medhin G; Mekasha B; Gundersen SG; Johannessen A
    BMC Gastroenterol; 2019 May; 19(1):74. PubMed ID: 31092203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HBsAg seroclearance further reduces hepatocellular carcinoma risk after complete viral suppression with nucleos(t)ide analogues.
    Yip TC; Wong GL; Chan HL; Tse YK; Lam KL; Lui GC; Wong VW
    J Hepatol; 2019 Mar; 70(3):361-370. PubMed ID: 30367899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of dose and duration of corticosteroid on the risk of hepatitis flare in patients with chronic hepatitis B.
    Wong GL; Yuen BW; Chan HL; Tse YK; Yip TC; Lam KL; Lui GC; Wong VW
    Liver Int; 2019 Feb; 39(2):271-279. PubMed ID: 30179316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of overall survival between antiviral-induced viral suppression and inactive phase chronic hepatitis B patients.
    Cho YY; Lee JH; Chang Y; Nam JY; Cho H; Lee DH; Cho EJ; Lee DH; Yu SJ; Lee JM; Kim YJ; Yoon JH
    J Viral Hepat; 2018 Oct; 25(10):1161-1171. PubMed ID: 29741286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population-based study of Entecavir and long-term mortality in chronic hepatitis B-related decompensated liver cirrhosis.
    Hung TH; Tsai CC; Lee HF
    Clin Res Hepatol Gastroenterol; 2019 Nov; 43(6):694-699. PubMed ID: 30922728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On-Treatment Improvement of MELD Score Reduces Death and Hepatic Events in Patients With Hepatitis B-Related Cirrhosis.
    Yip TC; Chan HL; Tse YK; Lam KL; Lui GC; Wong VW; Wong GL
    Am J Gastroenterol; 2018 Nov; 113(11):1629-1638. PubMed ID: 30315283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal on-treatment ALT during antiviral treatment is associated with a lower risk of hepatic events in patients with chronic hepatitis B.
    Wong GL; Chan HL; Tse YK; Yip TC; Lam KL; Lui GC; Wong VW
    J Hepatol; 2018 Oct; 69(4):793-802. PubMed ID: 29758335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term lamivudine for chronic hepatitis B and cirrhosis: A real-life cohort study.
    Su MH; Lu AL; Li SH; Zhong SH; Wang BJ; Wu XL; Mo YY; Liang P; Liu ZH; Xie R; He LX; Fu WD; Jiang JN
    World J Gastroenterol; 2015 Dec; 21(46):13087-94. PubMed ID: 26673249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of reimbursement program on liver-related mortality in patients with chronic hepatitis B in Beijing, China.
    Li M; Kong YY; Wu SS; Zhou JL; Wu XN; Wang L; Su JT; Ou XJ; You H; Xie XQ; Wei ZH; Jia JD
    J Dig Dis; 2019 Sep; 20(9):467-475. PubMed ID: 31231938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is HBV viral load at admission associated with development of acute-on-chronic liver failure in patients with acute decompensation of chronic hepatitis B related cirrhosis?
    Lei JH; Peng F; Chen Z; Xiao XQ
    BMC Infect Dis; 2019 Apr; 19(1):363. PubMed ID: 31039732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of adipokines with hepatic steatosis and fibrosis in chronic hepatitis B patients on long-term nucleoside analogue.
    Mak LY; Lee CH; Cheung KS; Wong DK; Liu F; Hui RW; Fung J; Xu A; Lam KS; Yuen MF; Seto WK
    Liver Int; 2019 Jul; 39(7):1217-1225. PubMed ID: 30912255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality Among Patients With Chronic Hepatitis B Infection: The Chronic Hepatitis Cohort Study (CHeCS).
    Bixler D; Zhong Y; Ly KN; Moorman AC; Spradling PR; Teshale EH; Rupp LB; Gordon SC; Boscarino JA; Schmidt MA; Daida YG; Holmberg SD;
    Clin Infect Dis; 2019 Mar; 68(6):956-963. PubMed ID: 30060032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B e antigen-negative chronic hepatitis B in Hong Kong.
    Chan HL; Leung NW; Hussain M; Wong ML; Lok AS
    Hepatology; 2000 Mar; 31(3):763-8. PubMed ID: 10706570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eight-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general population.
    Papatheodoridis GV; Sypsa V; Dalekos G; Yurdaydin C; van Boemmel F; Buti M; Goulis J; Calleja JL; Chi H; Manolakopoulos S; Loglio A; Siakavellas S; Gatselis N; Keskın O; Lehretz M; Savvidou S; de la Revilla J; Hansen BE; Kourikou A; Vlachogiannakos I; Galanis K; Idilman R; Colombo M; Esteban R; Janssen HLA; Berg T; Lampertico P
    J Hepatol; 2018 Jun; 68(6):1129-1136. PubMed ID: 29427727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes poses a higher risk of hepatocellular carcinoma and mortality in patients with chronic hepatitis B: A population-based cohort study.
    Shyu YC; Huang TS; Chien CH; Yeh CT; Lin CL; Chien RN
    J Viral Hepat; 2019 Jun; 26(6):718-726. PubMed ID: 30739359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.